Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $954.60 | 40 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $196.27 | 2 | $0 (2019) |
| ABBVIE INC. | $189.95 | 16 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $178.56 | 4 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $124.99 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.57 | 6 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $52.44 | 3 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $44.97 | 2 | $0 (2017) |
| Lilly USA, LLC | $33.29 | 2 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $24.30 | 1 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $16.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $37.24 | 2 | ABBVIE INC. ($22.90) |
| 2022 | $47.97 | 3 | ABBVIE INC. ($29.02) |
| 2021 | $21.38 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($21.38) |
| 2019 | $267.01 | 3 | Janssen Scientific Affairs, LLC ($124.99) |
| 2018 | $331.38 | 12 | Synergy Pharmaceuticals Inc ($178.56) |
| 2017 | $249.62 | 19 | AbbVie, Inc. ($110.15) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/15/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/10/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $14.34 | General |
| 07/09/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Immunology | ||||||
| 04/26/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/01/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $117.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/16/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Lower GI | ||||||
| 04/09/2019 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 07/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Lower GI | ||||||
| 07/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Lower GI | ||||||
| 07/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: Lower GI | ||||||
| 07/25/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: Lower GI | ||||||
| 04/24/2018 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $79.07 | General |
| 04/12/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $70.33 | General |
| Category: Gastroenterology | ||||||
| 04/12/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $70.33 | General |
| Category: Gastroenterology | ||||||
| 04/12/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Gastroenterology | ||||||
| 04/12/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Gastroenterology | ||||||
| 02/16/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Endocrinology | ||||||
| 01/12/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Endocrinology | ||||||
| 01/05/2018 | Ferring Pharmaceuticals Inc. | PREPOPIK (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Endocrinology | ||||||
| 11/17/2017 | Ferring Pharmaceuticals Inc. | PREPOPIK (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Endocrinology | ||||||
| 11/10/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 399 | 556 | $158,975 | $44,589 |
| 2022 | 11 | 579 | 724 | $236,125 | $54,506 |
| 2021 | 14 | 697 | 906 | $291,892 | $72,053 |
| 2020 | 12 | 577 | 761 | $247,376 | $60,838 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 123 | 264 | $40,392 | $15,936 | 39.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 140 | 149 | $32,482 | $12,606 | 38.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 26 | 26 | $23,634 | $4,877 | 20.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 47 | 47 | $22,090 | $3,322 | 15.0% |
| 43244 | Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | Facility | 2023 | 12 | 16 | $11,824 | $2,698 | 22.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 13 | $8,996 | $1,884 | 20.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 17 | 19 | $10,317 | $1,740 | 16.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $9,240 | $1,525 | 16.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 179 | 191 | $41,638 | $15,038 | 36.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 136 | 260 | $39,780 | $14,013 | 35.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 38 | 38 | $34,243 | $7,417 | 21.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 90 | 94 | $44,180 | $5,492 | 12.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $29,756 | $4,058 | 13.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 23 | 26 | $14,118 | $2,180 | 15.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $9,150 | $2,138 | 23.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 11 | 13 | $7,566 | $1,333 | 17.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $6,720 | $1,267 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 14 | $2,954 | $1,014 | 34.3% |
| 43236 | Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $6,020 | $555.75 | 9.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 218 | 240 | $53,594 | $19,368 | 36.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 164 | 341 | $52,173 | $18,768 | 36.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 40 | 40 | $36,360 | $7,438 | 20.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 88 | 92 | $43,240 | $5,661 | 13.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 45 | 45 | $31,140 | $4,848 | 15.6% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2021 | 19 | 19 | $14,041 | $3,072 | 21.9% |
About Dr. Jonathan Kushner, MD
Dr. Jonathan Kushner, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295791226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Kushner, MD has received a total of $954.60 in payments from pharmaceutical and medical device companies, with $37.24 received in 2023. These payments were reported across 40 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($954.60).
As a Medicare-enrolled provider, Kushner has provided services to 2,252 Medicare beneficiaries, totaling 2,947 services with total Medicare billing of $231,986. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Internal Medicine|Endocrinology, Diabetes & Metabolism
- Location Dayton, OH
- Active Since 04/26/2006
- Last Updated 10/16/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1295791226
Products in Payments
- Trulance (Drug) $178.56
- STELARA (Biological) $136.65
- XELJANZ (Drug) $117.20
- Creon (Drug) $110.82
- PREPOPIK (Drug) $52.44
- Amitiza (Drug) $50.19
- LINZESS (Drug) $49.50
- Humira (Biological) $27.21
- XIFAXAN (Drug) $25.22
- ULTRAFLEX TRACHEOBRONCHIAL STENT SYSTEM (Device) $24.30
- MOTEGRITY (Drug) $21.38
- UCERIS (Drug) $19.75
- TALTZ (Drug) $18.95
- SKYRIZI (Biological) $16.45
- HUMIRA (Biological) $12.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Dayton
Trisha Zeidan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $243,390
Dr. Deepak Sarwal, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $16,847
Thomas Koroscil, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $10,068
Ankur Gupta, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,584
Dr. Mangaiyarkkarasi Sivakumar, Md Ms, MD MS
Endocrinology, Diabetes & Metabolism — Payments: $18.48
Joann Findlay, Md, MD
Endocrinology, Diabetes & Metabolism